ESR2 and ovarian cancer: Chemerin protein and its receptor CMKLR1 were demonstrated to be abundantly detectable by immunohistochemistry in ovarian cancer tissues and to positively correlate with intratumoral expression of PR, ERβ and ERRs, corroborating interaction with estrogen signaling pathways as previously suggested.